11/13
07:46 am
bcab
BioAtla, Inc. (NASDAQ: BCAB) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating.
Medium
Report
BioAtla, Inc. (NASDAQ: BCAB) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating.
9/16
10:09 am
bcab
BioAtla, Inc. (NASDAQ: BCAB) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $5.00 price target on the stock.
Medium
Report
BioAtla, Inc. (NASDAQ: BCAB) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $5.00 price target on the stock.
9/16
10:09 am
bcab
BioAtla, Inc. (NASDAQ: BCAB) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $5.00 price target on the stock.
Medium
Report
BioAtla, Inc. (NASDAQ: BCAB) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $5.00 price target on the stock.
9/16
09:53 am
bcab
Rating for BCAB
Medium
Report
Rating for BCAB
9/16
09:53 am
bcab
Rating for BCAB
Medium
Report
Rating for BCAB